Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies

Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies

Rishi P Singh,1 Giovanni Staurenghi,2 Ayala Pollack,3 Adeniyi Adewale,4 Thomas M Walker,4 Dana Sager,4 Robert Lehmann5 1Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; 2Department of Biomedical and Clinical Science Luigi Sacco, Luigi Sacco Hospital, University of Milan, Milan,...

Full description

Bibliographic Details
Main Authors: Singh RP, Staurenghi G, Pollack A, Adewale A, Walker TM, Sager D, Lehmann R
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:Clinical Ophthalmology
Subjects:
cataract surgery
non-proliferative diabetic retinopathy
nepafenac 0.1%
postoperative macular edema
visual outcomes
Online Access:https://www.dovepress.com/efficacy-of-nepafenac-ophthalmic-suspension-01-in-improving-clinical-o-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/efficacy-of-nepafenac-ophthalmic-suspension-01-in-improving-clinical-o-peer-reviewed-article-OPTH

Similar Items